The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study.
暂无分享,去创建一个
S. Yusuf | E. Lonn | H. Gerstein | K. Teo | K. Malmberg | S. Anand | V. Vuksan | M. McQueen | Q. Yi
[1] S. Yusuf,et al. Effects of Ramipril and Vitamin E on Atherosclerosis: The Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE) , 2001, Circulation.
[2] N. Wareham,et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) , 2001, BMJ : British Medical Journal.
[3] B. Fagerberg,et al. Insulin resistance and intima–media thickness in the carotid and femoral arteries of clinically healthy 58‐year‐old men. The Atherosclerosis and Insulin Resistance Study (AIR) , 2001, Journal of internal medicine.
[4] E. Feskens,et al. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.
[5] T. Elatrozy,et al. Insulin resistance, cardiovascular risk factors and ultrasonically measured early arterial disease in normotensive Type 2 diabetic subjects , 2000, Diabetes/metabolism research and reviews.
[6] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[7] R N Bergman,et al. Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study). , 2000, The American journal of cardiology.
[8] T. Miida,et al. Possible risk factors of carotid artery atherosclerosis in the Japanese population: a primary prevention study in non-diabetic subjects. , 2000, Internal medicine.
[9] P. Nilsson,et al. Relation between insulin resistance and carotid intima‐media thickness and stenosis in non‐diabetic subjects. Results from a cross‐sectional study in Malmö, Sweden , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[10] Y. Friedlander,et al. Fasting plasma glucose in non-diabetic elderly women predicts increased all-causes mortality and coronary heart disease risk. , 2000, Australian and New Zealand journal of medicine.
[11] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[12] S. Yusuf,et al. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). , 2000, Indian heart journal.
[13] E. Feskens,et al. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.
[14] P. Savage,et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria , 1999, The Lancet.
[15] L. Bouter,et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study , 1999, Diabetologia.
[16] M. Harris,et al. Diabetes and decline in heart disease mortality in US adults. , 1999, JAMA.
[17] S. Yusuf,et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.
[18] S. Nitter‐Hauge,et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. , 1999, Diabetes care.
[19] S. Yusuf,et al. The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. , 1998, The Canadian journal of cardiology.
[20] A. Rantala,et al. Hyperinsulinemia and Carotid Atherosclerosis in Hypertensive and Control Subjects , 1998, Diabetes Care.
[21] A. Avignon,et al. Nonfasting Plasma Glucose is a Better Marker of Diabetic Control Than Fasting Plasma Glucose in Type 2 Diabetes , 1997, Diabetes Care.
[22] H. Takaki,et al. Insulin resistance as an independent risk factor for carotid artery wall intima media thickening in vasospastic angina. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[23] A. Folsom,et al. Glycosylated Hemoglobin Level and Carotid Intimal-Medial Thickening in Nondiabetic Individuals: The Atherosclerosis Risk in Communities Study , 1997, Diabetes Care.
[24] S. Haffner,et al. A Prospective Analysis of the HOMA Model: The Mexico City Diabetes Study , 1996, Diabetes Care.